Caption Management’s Replimune Group REPL Stock Holding History

Caption Management’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$612K	Sell	80,000 -5,000	-6%	-$38.2K	﹤0.01%	1158
2025 Q4	$826K	Buy	+85,000	New	+$723K	0.01%	1123
2025 Q3	–	Sell	-445,600	Closed	-$4.14M	–	1979
2025 Q2	$4.14M	Buy	+445,600	New	+$3.89M	0.05%	454
2023 Q4	–	Sell	-225,000	Closed	-$3.85M	–	1614
2023 Q3	$3.85M	Buy	+225,000	New	+$4.42M	0.06%	388

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Caption Management's REPL Position: Q1 2026 in Review

Caption Management increased its Replimune Group (REPL) stake by 98% in Q1 2026, buying an estimated $1.71M and bringing the position to 451,822 shares worth $3.46M. The position accounts for 0.02% of the portfolio, ranked #646.

Caption Management first reported a position in REPL in Q2 2023 and has held it in 5 quarters since. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

Caption Management held 451,822 shares of Replimune Group worth $3.46M as of Q1 2026.
Caption Management bought 223,252 Replimune Group shares in Q1 2026, an estimated $1.71M.
Replimune Group made up 0.02% of Caption Management's portfolio in Q1 2026, its #646 holding.
Caption Management first reported a position in Replimune Group in Q2 2023 and has held it in 5 quarters since.
180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.